Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Extracellular ionized calcium refers to the fraction of calcium in the blood and extracellular fluid that exists in a free, unbound, and biologically active state[4][7]. This pool constitutes about 45–50% of total serum calcium, with the remainder being protein-bound (mostly to albumin) or complexed with anions[4][7]. Ionized calcium is tightly regulated by parathyroid hormone, vitamin D, and calcitonin, coordinating calcium absorption in the gut, reabsorption in the kidney, and exchange with bone[3]. It is essential for numerous physiological processes, including neuromuscular activity, vascular contractility, hormone and neurotransmitter secretion, blood coagulation, and enzymatic reactions[3][4][7]. Levels of extracellular ionized calcium are commonly measured as a biomarker for calcium homeostasis and are crucial in diagnosing and managing metabolic, renal, skeletal, and neuromuscular disorders[4][7]. However, “extracellular free ionized calcium pool” is not a protein, receptor, enzyme, transporter, or classical therapeutic target, but rather a physiochemical state or compartment of the calcium ion in extracellular fluids. Interventions typically target the calcium-sensing receptor (CaSR), parathyroid hormone axis, or associated pathways, not the pool itself[4][7]. Thus, it is not considered a molecular drug target on its own, but a critical physiological parameter monitored in clinical practice.
Supplementation to restore extracellular calcium levels; Inhibition or stimulation of calcium-sensing receptor (CaSR) to modulate parathyroid hormone secretion and calcium homeostasis; Chelation to reduce free extracellular calcium; Inhibition of osteoclast activity to reduce bone calcium release; Promotion of intestinal calcium absorption
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Extracellular ionized calcium.